INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 6.00
0.00 (0.00%)
At close: Sep 18, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 644.85 million as of September 18, 2026. Its market cap has increased by 48.59% in one year.
Market Cap
644.85M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.00
ChartMarket Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has increased from 452.37M to 644.85M, an increase of 42.55%. That is a compound annual growth rate of 8.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 644.85M | 68.86% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.54B |
| Circio Holding ASA | 3.25B |
| Nordhealth AS | 1.97B |
| Thor Medical ASA | 1.95B |
| ArcticZymes Technologies ASA | 1.07B |
| Omda AS | 896.18M |
| Vistin Pharma ASA | 838.11M |
| Lytix Biopharma ASA | 645.96M |